• >>
  • Pharmaceuticals and Healthcare

Epilepsy Drugs Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240290
21st May, 2018
Region : Global
Pages
CHOOSE LICENCE TYPE

COVID-19


Understand the influence of COVID-19 on the Epilepsy Drugs Market with our analysts monitoring the situation across the globe.






Description

Global Epilepsy Drugs market, by generation of drugs (first-generation, second-generation and third-generation), spectrum of activity (narrow-spectrum and broad-spectrum) and seizure type (partial onset seizures and generalized seizures). 


Market Scenario:
Epilepsy is a group of neurological disorders. These neurological disorders characterized by epileptic seizures. These Epileptic seizures are episodes which can result into physical injuries, including broken bones occasionally. In most of the cases cause of epilepsy is not known. Through the process of epileptogenesis, some cases occur as the result of brain injury, stroke, brain tumors, infections of the brain and birth defects. To a small proportion of cases, genetic mutations are directly linked. Excessive and abnormal neuronal activity in the cortex of the brain leads to Epileptic seizures.

 
Although, the exact mechanism of epilepsy is not known, a very less is known about its cellular and network mechanisms. But still it is not known, under which circumstances the brain shifts into the activity of a seizure. Repeated seizures are the main symptom of epilepsy.


By performing electroencephalogram (EEG), Epilepsy can be confirmed. Looking for abnormal patterns of brain waves and neuroimaging (CT scan or MRI) and then at the structure of the brain.
Once a second seizure has occurred, Epilepsy is treated with daily medication generally. The Anti-epileptic drugs (AEDs) are generally taken orally. The drug is prescribed by the Doctor, seeing the type of seizure. Although patients do not react to the drugs in the same way, AEDs appear to help control seizures in 70 % of the cases.
Patients with epilepsy are 11 times more likely to experience premature death in comparison with others.  


Human brain is the source of epilepsy. Epilepsy is one of the most common neurological diseases, as per the World Health Organization (WHO); nearly 50 million people have epilepsy worldwide.
Due to huge patient base and increasing incidences of neurological disorders, these factors will fuel the growth of Epilepsy Drugs market. 


Segmentation:
The Epilepsy Drugs market is segmented on the basis of generation of drugs, spectrum of activity, seizure type and region.
On the basis of generation of drugs, the market is segmented into first-generation, second-generation and third-generation.
On the basis of spectrum of activity, the market is segmented into narrow-spectrum and broad-spectrum. 
On the basis of seizure type, the market is segmented into partial onset seizures and generalized seizures.


Regional Analysis:
Geographically, the Epilepsy Drugs market is segregated in North America, Europe, Asia Pacific, and LAMEA (Latin America, Middle East and Africa). 
Key Players:
The major key players in Epilepsy Drugs market are: Abbott Laboratories, Cephalon, Inc., Eisai Co., Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., Sunovion Pharmaceuticals, Inc., UCB Pharma Ltd., Valeant pharmaceuticals International, Inc.


Segmentation:


By Generation of Drugs
• First-generation
• Second-generation
• Third-generation


By Spectrum of Activity
• Narrow-spectrum
• Broad-spectrum


By Seizure Type
• Partial onset seizures
• Generalized seizures 


By Geography:
• North America
• Europe
• Asia-Pacific
• LAMEA

Research Scope
 
The study for Global Epilepsy Drugs Market Survey and Trend Research 2018 will provide market size, estimates and forecast based on the following years: 
 
Historic data: 2015-16  Base Year Estimate: 2017  Forecast: 2018 to 2025
The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 
Our analyst implement, several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 


1. Introduction
1.1. Market Definition
1.2. Market Scope


2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions


3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016 


4. Generation of Drugs Overview
4.1. Introduction 
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. First-generation
4.2.2. Second-generation
4.2.3. Third-generation
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Spectrum of Activity Overview
5.1. Introduction 
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. Narrow-spectrum
5.2.2. Broad-spectrum
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. Seizure Type Overview
6.1. Introduction 
6.2. Market Size & Forecast, 2015 to 2025
6.2.1. Partial onset seizures
6.2.2. Generalized seizures 
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


7. Regional Overview
7.1. Introduction
7.2. Market Size & Forecast, 2015 to 2025
7.2.1. North America
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.1.3. Mexico 
7.2.2. Europe
7.2.2.1. UK
7.2.2.2. Germany
7.2.2.3. France
7.2.2.4. Italy 
7.2.2.5. Russia
7.2.2.6. Poland
7.2.2.7. Rest of Europe
7.2.3. Asia-Pacific
7.2.3.1. China
7.2.3.2. India
7.2.3.3. Japan
7.2.3.4. Australia
7.2.3.5. South Korea
7.2.3.6. Rest of Asia-Pacific
7.2.4. LAMEA
7.2.4.1. Saudi Arabia
7.2.4.2. UAE
7.2.4.3. South Africa
7.2.4.4. Rest of LAMEA
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


8. Manufacturer/ Vendor Profile
8.1. The following attributes will be considered while profiling key manufacturers in this industry: 
8.1.1. Company Overview
8.1.2. Financial Synopsis
8.1.3. Recent Developments
8.1.4. R&D Investments (if any)
8.1.5. Strategy Overview (Analyst Perspective)
8.1.6. Product Portfolio
8.2. Companies Profiled
8.2.1. Abbott Laboratories
8.2.2. Cephalon, Inc.
8.2.3. Eisai Co., Ltd.
8.2.4. GlaxoSmithKline plc.
8.2.5. Johnson & Johnson
8.2.6. Novartis AG
8.2.7. Pfizer, Inc.
8.2.8. Sanofi S.A. 
8.2.9. Sunovion Pharmaceuticals, Inc.
8.2.10. UCB Pharma Ltd.
8.2.11. Valeant Pharmaceuticals International, Inc.
(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 


What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

Report ID :240290

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

Report ID :240290

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Epilepsy Drugs Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
  • Impact of COVID on supply/demand scenario, trade landscape & supply chain
  • How market participants are preparing/strategizing to combat the impact
  • How does the short-term & long-term scenario for Epilepsy Drugs Market looks like

Report ID :240290

Published Date :21st May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports


  • Data Security
  • Your data is safe and secure


  • Vast Report Database
  • We have more than 2 Million reports in our database


  • Client Focused
  • Personalized updates and 24*7 support


  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support


  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie


  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports